General Information of Drug Inactive Ingredient (DIG) (ID: E00310)

DIG Name
Glyceryl monostearate
Synonyms
Glyceryl monostearate; Monostearin; 123-94-4; GLYCEROL MONOSTEARATE; 31566-31-1; Glyceryl stearate; 1-Stearoyl-rac-glycerol; Tegin; 1-MONOSTEARIN; Octadecanoic acid, 2,3-dihydroxypropyl ester; 1-Glyceryl stearate; Stearic acid 1-monoglyceride; Stearin, 1-mono-; 1-Monostearoylglycerol; Sandin EU; Glycerin 1-monostearate; Glycerol 1-monostearate; Aldo MSD; Aldo MSLG; Glycerin 1-stearate; Glycerol 1-stearate; Stearoylglycerol; Arlacel 165; Tegin 55G; alpha-Monostearin; Emerest 2407; Aldo 33; Aldo 75; 2,3-dihydroxypropyl octadecanoate; Glyceryl 1-monostearate; Glycerin monostearate; 3-Stearoyloxy-1,2-propanediol; Glycerol alpha-monostearate; .alpha.-Monostearin; Monoglyceryl stearate; Tegin 515; Monostearate (glyceride); Glyceryl monooctadecanoate; 1-octadecanoyl-rac-glycerol; NSC 3875; Stearic acid, monoester with glycerol; 2,3-Dihydroxypropyl stearate; NSC3875; MONOSTEARIN (L); rac-1-monostearoylglycerol; Glycerol .alpha.-monostearate; MG(18:0/0:0/0:0)[rac]; CHEBI:75555; Stearic acid .alpha.-monoglyceride; MFCD00036186; Octadecanoic acid, monoester with 1,2,3-propanetriol; NCGC00164529-01; DSSTox_CID_9160; DSSTox_RID_78691; DSSTox_GSID_29160; Cefatin; Dermagine; Monelgin; Sedetine; Admul; Orbon; Citomulgan M; Drewmulse V; Cerasynt S; Drewmulse TP; Cerasynt SD; Cerasynt SE; Cerasynt WM; Cyclochem GMS; Drumulse AA; Protachem GMS; Witconol MS; Witconol MST; Unimate GMS; Ogeen M; Stearin, mono-; Emcol CA; Emcol MSK; Hodag GMS; Ogeen GRB; Ogeen MAV; Aldo HMS; Aldo MS; Celinhol - A; (+/-)-2,3-Dihydroxypropyl octadecanoate; 1-Glyceryl stearate; 1-Monooctadecanoylglycerol; 1-Monostearin; CAS-123-94-4; Armostat 801; Myvaplex 600; Stearic monoglyceride; Kessco 40; Abracol S.L.G.; Advawax 140; Arlacel 161; Arlacel 169; FEMA No. 2527; Imwitor 191; Imwitor 900K; Atmul 67; Atmul 84; Starfol GMS 450; Starfol GMS 600; Starfol GMS 900; Stearic acid alpha-monoglyceride; Cerasynt 1000-D; Emerest 2401; Aldo-28; Aldo-72; Atmos 150; Atmul 124; Estol 603; Glycerol stearate, pure; Grocor 5500; Grocor 6000; Ogeen 515; Tegin 503; Lipo GMS 410; Lipo GMS 450; Lipo GMS 600; EINECS 204-664-4; EINECS 245-121-1; USAF KE-7; EMUL P.7; TEGIN 90; (R)-2,3-Dihydroxypropyl stearate; 22610-63-5; Glyceryl monostearate [JAN:NF]; Tegin (Related); 1-MONOSTEAROYL-rac-GLYCEROL; (1)-2,3-Dihydroxypropyl stearate; 1,2,3-Propanetriol, homopolymer, isooctadecanoate; 1,2,3-Propanetriol, homopolymer, monooctadecanoate; EINECS 250-705-4; 1,2,3-Propanetriol monooctadecanoate; Eastman 600; 1-O-stearoylglycerol; 1-octadecanoylglycerol; Monostearin (Related); Glycerol Mono Stearate; rac-octadecanoylglycerol; Triglyceryl monostearate; Polyglyceryl-3 stearate; glycerol 1-octadecanoate; Glyceryl 1-octadecanoate; rac-glyceryl monostearate; AI3-00966; Tegin 515 (Related); Glycerol .alpha.-sterate; (+-)-1-stearoylglycerol; Glyceryl monopalmitostearate; EC 250-705-4; SCHEMBL4488; (+-)-glyceryl monostearate; Geleol mono and diglycerides; Glyceryl stearate (Related); DSSTox_RID_78757; DSSTox_GSID_29304; Glycerol monostearate (GMS); (+-)-1-monostearoylglycerol; (+-)-1-octadecanoylglycerol; 37349-34-1; 83138-62-9; Stearin, 1-mono- (8CI); Glycerol monostearate, purified; CHEMBL255696; Glyceryl monostearate (Related); 2,3-Dihydroxypropyl stearate #; DTXSID7029160; CHEBI:75557; Glyceryl monostearate (JP17/NF); 1-Stearoyl-rac-glycerol, >=99%; NSC-3875; EINECS 238-880-5; Tox21_112160; Tox21_202573; Tox21_301104; ANW-27153; LMGL01010003; rac-2,3-dihydroxypropyl octadecanoate; AKOS015901589; Tox21_112160_1; DB11250; MCULE-2198239945; (+-)-2,3-dihydroxypropyl octadecanoate; NCGC00164529-02; NCGC00164529-03; NCGC00164529-04; NCGC00255004-01; NCGC00260122-01; Octadecanoic acid,3-dihydroxypropyl ester; 1,2,3-Propanetriol 1-octadecanoyl ester; 85666-92-8; AK175522; Octadecanoic acid, monoester with 3,3'-((2-hydroxy-1,3-propanediyl)bis(oxy))bis(1,2-propanediol-; P566; CAS-11099-07-3; FT-0626740; FT-0626748; FT-0674656; G0085; Octadecanoic acid, 2.3-dihydroxypropyl ester; ST51037333; 1379-EP2270002A1; 1379-EP2270006A1; 1379-EP2270011A1; 1379-EP2277861A1; 1379-EP2277865A1; 1379-EP2281823A2; 1379-EP2289892A1; 1379-EP2292234A1; 1379-EP2292593A2; 1379-EP2295406A1; 1379-EP2295409A1; 1379-EP2295424A1; 1379-EP2295426A1; 1379-EP2295427A1; 1379-EP2298742A1; 1379-EP2298747A1; 1379-EP2298766A1; 1379-EP2298772A1; 1379-EP2301536A1; 1379-EP2301538A1; 1379-EP2301922A1; 1379-EP2301931A1; 1379-EP2305641A1; 1379-EP2305648A1; 1379-EP2308492A1; 1379-EP2308839A1; 1379-EP2308869A1; 1379-EP2311455A1; 1379-EP2311821A1; 1379-EP2311829A1; 1379-EP2314590A1; 1379-EP2316452A1; 1379-EP2374792A1; 3889-EP2295430A2; 3889-EP2295431A2; 3889-EP2305668A1; 3889-EP2374787A1; D01947; SR-01000944874; Q-201168; Q5572563; SR-01000944874-1; W-110285; Octadecanoic acid, monoester with tri-1,2,3-propanetriol diether; 342394-34-7
DIG Function
Emollient; Emulsifying agent; Emulsion stabilizing agent; Solubilizing agent; Surfactant; Viscosity-controlling agent
Formula
C21H42O4
Canonical SMILES
CCCCCCCCCCCCCCCCCC(=O)OCC(CO)O
InChI
1S/C21H42O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21(24)25-19-20(23)18-22/h20,22-23H,2-19H2,1H3
InChIKey
VBICKXHEKHSIBG-UHFFFAOYSA-N
Physicochemical Properties Molecular Weight 358.6 Topological Polar Surface Area 66.8
XlogP 7.4 Complexity 281
Heavy Atom Count 25 Rotatable Bond Count 20
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 4

Full List of Drug(s) Co-administrated with This DIG

25 Approved Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Amlexanox DM0DQM5 Respiratory tract inflammation [CA07] Amlexanox 5% paste F23624
Aspirin DM672AH Acute coronary syndrome [BA41] Aspirin 81 mg tablet F01812
Azelaic Acid DMHVL0J Acne vulgaris [ED80] Azelaic Acid 20% cream F23633
Clarithromycin DM4M1SG Acute maxillary sinusitis [] Clarithromycin 500 mg tablet F04455
crisaborole DMNVKU6 Atopic dermatitis [EA80] Crisaborole 2% ointment F24258
Desonide DMTP2NJ Allergic rhinitis [CA08.0] Desonide 0.05% lotion F23703
Dexlansoprazole DM1DBV5 Erosive esophagitis [DA25.0] Dexlansoprazole 30 mg tablet F05486
Diclofenac DMPIHLS Chronic renal failure [GB61.Z] Diclofenac 75 mg tablet F05770
Esomeprazole DM7BN0X Cystic fibrosis [CA25] Esomeprazole 20 mg capsule F07491
Fluocinonide DM65KL8 Exanthem [] Fluocinonide 0.1% cream F23750
Glipizide DMZA5PQ Diabetic complication [5A2Y] Glipizide 5 mg tablet F09259
Halcinonide DMGLAX1 Exanthem [] Halcinonide 0.1% cream F23763
Hydroxyzine DMF8Y74 Allergic rhinitis [CA08.0] Hydroxyzine 25 mg tablet F09955
Ibuprofen DM8VCBE Dysmenorrhea [GA34.3] Ibuprofen 200 mg tablet F10286
Lamotrigine DM8SXYG Bipolar disorder [6A60] Lamotrigine 250 mg tablet F11221
Lovastatin DM9OZWQ Arteriosclerosis [BD40] Lovastatin 20 mg tablet F12608
Metoprolol DMOJ0V6 Acute coronary syndrome [BA41] Metoprolol 100 mg tablet F13729
Naproxen DMZ5RGV Bursitis [] Naproxen 375 mg tablet F14893
Nitroglycerin DMQ2491 Angina pectoris [BA40] Nitroglycerin 0.3 mg tablet F15451
Omeprazole DM471KJ Cystic fibrosis [CA25] Omeprazole 20 mg tablet F15905
Permethrin DMZ0Q1G Pediculus capitis infestation [1G00.0] Permethrin 5% cream F23868
Sulfacetamide DMZ6VEY Acne vulgaris [ED80] Sulfacetamide 10% cream F23909
Sulfasalazine DMICA9H Irritable bowel syndrome [DD91.0] Sulfasalazine 500 mg tablet F20487
Tamsulosin DM5QF9V Benign prostatic hyperplasia [GA90] Tamsulosin 0.4 mg capsule F20663
Topotecan DMP6G8T Central nervous system neoplasm [] Topotecan 0.25 mg capsule F21388
------------------
⏷ Show the Full List of 25 Approved Drug(s)